A multicenter analysis of prognostic factors in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib.

被引：0
|
作者：
Smith, Alan D.
Chan, Kelvin K.
Lim, Howard John
Cheung, Winson Y.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] Princess Margaret Hosp, Sunnybrook Odette Canc Ctr, Toronto, ON M4X 1K9, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14532
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Serum Glycan as a Prognostic Marker in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
    Miyahara, Koji
    Nouso, Kazuhiro
    Miyake, Yasuhiro
    Nakamura, Shinichiro
    Obi, Shuntaro
    Amano, Maho
    Hirose, Kazuko
    Nishimura, Shin-ichiro
    Yamamoto, Kazuhide
    HEPATOLOGY, 2014, 59 (01) : 355 - 356
  • [22] IGF-Child-Pugh score as a predictor of treatment outcome in advanced hepatocellular carcinoma patients treated with sorafenib.
    Abugabal, Yehia I.
    Hassan, Manal
    Pestana, Roberto
    Xiao, Lianchun
    Girard, Lauren
    Raghav, Kanwal Pratap Singh
    Morris, Jeffrey
    Abdel-Wahab, Reham
    Wolff, Robert A.
    Yao, James C.
    Amin, Hesham M.
    Kaseb, Ahmed Omar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] TUMOR NECROSIS AS A CORRELATE FOR RESPONSE IN SUBGROUP OF PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH SORAFENIB
    Abou-Alfa, G. K.
    Zhao, B.
    Capanu, M.
    Guo, P.
    Liu, F.
    Jacobs, G.
    Gansukh, B.
    Moscovici, M.
    Lentini, G.
    Schwartz, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 178 - 178
  • [24] Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenib
    Wada, Y.
    Takami, Y.
    Matsushima, H.
    Ryu, T.
    Mikagi, K.
    Saitsu, H.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S630 - S631
  • [25] Serum mass spectrometry analysis in hepatocellular carcinoma (HCC) patients treated with sorafenib (S)
    Chelis, L.
    Kakolyris, S.
    Mimidis, K.
    Xenidis, N.
    Amarantidiss, K.
    Meyer, K.
    Roder, H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S466 - S466
  • [26] Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol
    Gardini, Andrea Casadei
    Faloppi, Luca
    Aprile, Giuseppe
    Brunetti, Oronzo
    Caparello, Chiara
    Corbelli, Jody
    Chessa, Luchino
    Bruno, Daniele
    Ercolani, Giorgio
    Leonetti, Alessandro
    de Stefano, Giorgio
    Farella, Nunzia
    Foschi, Francesco Giuseppe
    Lanzi, Arianna
    Dadduzio, Vincenzo
    Marisi, Giorgia
    Masi, Gianluca
    Negri, Francesca, V
    Pagan, Flavia
    Santini, Daniele
    Scarpi, Emanuela
    Silletta, Marianna
    Silvestris, Nicola
    Tamburini, Emiliano
    Tassinari, Davide
    Vivaldi, Caterina
    Gentilucci, Umberto Vespasiani
    Zagonel, Vittorina
    Calvetti, Lorenzo
    Cascinu, Stefano
    Frassineti, Giovanni Luca
    Scartozzi, Mario
    TUMORI JOURNAL, 2018, 104 (06): : 476 - 479
  • [27] Advanced hepatocellular cancer treated with sorafenib analysis of prognostic factors for patients' survival: single institution experience
    Nowara, E.
    Nieckula, J.
    Mianowska-Malec, M.
    Huszno, J.
    ANNALS OF ONCOLOGY, 2016, 27 : 29 - 29
  • [28] SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH ADVANCED LIVER DISEASE
    Alves, Rogerio C.
    Alves, Daniele E.
    Guz, Betty
    Viana, Monica V.
    Harriz, Michelle C.
    Matos, Carla A.
    Terrabuio, Deborah
    Chagas, Aline
    Moutinho, Renata D.
    Taddeo, Eliane F.
    Duarte, Kelly C.
    Oliveira, George P.
    Ribeirol, Juliana M.
    Kondo, Mario
    Gampel, Otavio
    Poletti, Paula
    HEPATOLOGY, 2010, 52 (04) : 1193A - 1193A
  • [29] Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC)
    Ziogas, Dimitrios
    Thillai, Kiruthikah
    Korantzis, Ippokratis
    Chowdhury, M. H. Ruhe
    Papadatos-Pastos, Dionysios
    Suddle, Abid
    O'Grady, John
    Heaton, Nigel
    Ross, Paul J.
    Sarker, Debashis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [30] Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC)
    Ziogas, Dimitris
    Thillai, Kiruthikah
    Papadatos-Pastos, Dionysios
    Chowdhury, Mahfuja Hussain Ruhe
    Korantzis, Ippokratis
    Manickavasagar, Thubeena
    Suddle, Abid
    O'Grady, John
    Heaton, Nigel
    Ross, Paul J.
    Sarker, Debashis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345